Electrolux Nomination Committee s proposal for election of board members
STOCKHOLM, Feb. 1, 2021 /PRNewswire/
In preparation for the Electrolux Annual General Meeting on March 25, Electrolux Nomination Committee has decided to propose the re-election of all board members except Kai Wärn, who has declined re-election. Staffan Bohman is proposed to be re-elected as Chairman of the Board of Directors, and Petra Hedengran, Henrik Henriksson, Ulla Litzén, Karin Overbeck, Fredrik Person, David Porter and Jonas Samuelson as Board Members.
The Nomination Committee comprises Johan Forssell (Chairman), Investor AB, Carina Silberg, Alecta, Tomas Risbecker, AMF – Försäkring och Fonder, and Marianne Nilsson, Swedbank Robur Funds. The committee also includes Staffan Bohman and Fredrik Persson, chairman and member respectively, of the Electrolux Board.
1 Introduction
1.1 Listings of Special Purpose Acquisition Companies
( SPACs ) have been popular in the US
for a long time, including in the last decade. Despite high
activity in the Swedish IPO market, with record breaking numbers of
transaction and great demand for new IPOs (also for companies that
are in early phase and not yet profitable), SPACs have yet to be
introduced in Sweden. We have, however, noted an increased interest
from clients around the possibility to launch a Swedish SPAC and in
this memorandum, we outline the basic concept of a SPAC and
describe key issues/hurdles to be considered in relation to Swedish
SEB revises financial targets to support customers through increased financial flexibility
SEB’s Board of Directors has revised the financial targets for the group, with the objective to create further financial flexibility to better support the bank’s customers over time. According to the new targets, the bank will maintain a Common Equity Tier 1 capital ratio of 100-300 basis points above the regulatory requirement and pay a yearly dividend of around 50 per cent of earnings per share, and distribute potential capital in excess of the targeted capital position mainly through share repurchases.
SEB’s financial targets, with effect from 2021, are:
Alligator Bioscience s rights issue oversubscribed
STOCKHOLM, Jan. 27, 2021 /PRNewswire/
Alligator Bioscience AB (publ) ( Alligator or the Company ) has completed the share issue with pre-emption rights for the Company s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the Rights Issue ). The subscription period ran from and including January 11, 2021 to and including January 25, 2021. Through the Rights Issue, Alligator receives approximately SEK 86 million before deduction of issue costs. 13 895 925 shares, corresponding to approximately 97 per cent of the Rights Issue, were subscribed for by exercise of subscription rights (including subscription undertakings). Furthermore, 9 305 467 shares were subscribed for without subscription rights, corresponding to approximately 65 per cent of the Rights Issue. In total, the Rights Issue was subscribed for at 163 per cen
(2)
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT AND IN THE OFFER DOCUMENT WHICH WILL BE PUBLISHED SHORTLY BEFORE THE BEGINNING OF THE ACCEPTANCE PERIOD FOR THE OFFER.